Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study

• Asıl Yazarlar: Min-Lan Tsai (Yazar), Hsiu-Chen Lin (Yazar), Chiung-Hui Yen (Yazar), Jung-Tzu Ku (Yazar), Shian-Ying Sung (Yazar), Hsi Chang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2022-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

(1) Background: Cysteinyl leukotriene receptor antagonists (LTRAs), including montelukast and zafirlukast, are FDA-approved for treating pediatric asthma and allergic diseases. Tourette syndrome (TS), a common neuropsychiatric disorder in children, is associated with allergic diseases and asthma. In...